178
From a
Retail
Investor's
Perspective
There is a lack of genetic diversity. This is not a new idea by any stretch and is deemed as just a “given”. So we have a genetic bottleneck perpetuated by cloning and other strategies such as feminization. We can appreciate why this is being done because there is a medical case to be made for discouraging genetic diversity should male plants be allowed to do their thing. Medically, you can argue that you want consistent repeatable harvests generation after generation. And in there just may be the answer that forms the roots of the hypothesis.
Groundbreaking genetic research by BioRx…. Demonstrated that strains with identical names could have little if anything in common when it comes to genetic traits. In other words, we may find a movement away from using strain names (at least for scientific and medical purposes) and a move towards descriptors based on genetics and composition. Permission was granted to use content from BioRx’s report – this image below clearly depicts how strains with the same name may have little to nothing in common. Click on image to enlarge.
Click on image to enlarge